Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Annals of Surgical Oncology|November 6, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate CancersNina M Clark, Emma A Roberts, Catherine Fedorenko, et al.Gynecologic Oncology|August 28, 2021
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomasSahana Somasegar, Arielle S Weiss, Barbara M Norquist, et al.Gynecologic Oncology|February 27, 2019
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinomaChristopher B Morse, Mirna N Toukatly, Mark R Kilgore, et al.Gynecologic Oncology|December 25, 2012
Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testingBarbara M Norquist, Kathryn P Pennington, Kathy J Agnew, et al.Cold Spring Harbor Molecular Case Studies|October 8, 2020
Helicase-inactivating <i>BRIP1</i> mutation yields Fanconi anemia with microcephaly and other congenital abnormalitiesLara Kamal, Sarah B Pierce, Christina Canavati, et al.Gynecologic Oncology|December 30, 2020
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutationsTalayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, et al.Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.Gynecologic Oncology|August 11, 2024
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutationsXin Ray Tee, Emma Hazard, Elena Latorre-Esteves, et al.American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.Pageof 5